Pages that link to "Q69919512"
Jump to navigation
Jump to search
The following pages link to A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis (Q69919512):
Displaying 27 items.
- A clinical and economic review of disease-modifying antirheumatic drugs (Q28188829) (← links)
- Leucopenia during sulphasalazine treatment for rheumatoid arthritis (Q33561793) (← links)
- Slow drugs: slow progress? Use of slow acting antirheumatic drugs (SAARDs) in rheumatoid arthritis (Q33564477) (← links)
- Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis (Q33564501) (← links)
- A 10 year follow up of parenteral gold therapy in patients with rheumatoid arthritis (Q33578782) (← links)
- Sulfasalazine for rheumatoid arthritis (Q33908146) (← links)
- Efficacy and toxicity of old and new disease modifying antirheumatic drugs (Q34071262) (← links)
- Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept (Q34595156) (← links)
- Methotrexate intolerance in elderly patients with rheumatoid arthritis: what are the alternatives? (Q35182959) (← links)
- The treatment of rheumatoid arthritis (Q35859217) (← links)
- Efficacy, tolerability and cost effectiveness of disease-modifying antirheumatic drugs and biologic agents in rheumatoid arthritis (Q36062038) (← links)
- The impact of endpoint measures in rheumatoid arthritis clinical trials (Q36206897) (← links)
- Sulfasalazine: a review of its use in the management of rheumatoid arthritis (Q36237544) (← links)
- The use of sulphasalazine as a disease modifying antirheumatic drug (Q37614364) (← links)
- The gold complexes (Q37799080) (← links)
- Non-biologic disease-modifying antirheumatic drugs (DMARDs) improve pain in inflammatory arthritis (IA): a systematic literature review of randomized controlled trials. (Q38071925) (← links)
- New perspectives of secondary and tertiary therapy for rheumatoid arthritis (Q38658280) (← links)
- Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis (Q40432257) (← links)
- Advances and issues in the pharmacotherapy of rheumatoid arthritis (Q40434105) (← links)
- Sulphasalazine in the treatment of children with chronic arthritis (Q42538496) (← links)
- Evaluation of antineutrophil cytoplasmic antibody seroconversion induced by minocycline, sulfasalazine, or penicillamine (Q43510053) (← links)
- Cortical stimulation in conscious rats controls joint inflammation. (Q52664275) (← links)
- Treatment of rheumatoid arthritis (Q56060521) (← links)
- The effect of elbow flexion and time of assessment on the measurement of grip strength in rheumatoid arthritis (Q67579388) (← links)
- Long-term effects of treating rheumatoid arthritis (Q68094980) (← links)
- Intra-articular steroids: confounder of clinical trials (Q70220749) (← links)
- Rheumatoid arthritis (Q83860921) (← links)